Additionally, TMZ treatment (TMZ group) retarded tumor growth compared with the NC group, and the group with treatment in combination with shRPN2 and TMZ (sh-RPN2 + TMZ) showed the smallest tumor volume in comparison to the other groups (Fig.4a, b). The gene discussed is RPN2; the disease is neoplasm.